Last reviewed · How we verify

NCT03448848

Role of Branched-chain Amino Acids Infusion as Adjunct Therapy Post Liver Surgery for Patients in Intensive Care Unit

Completed NA Last updated 21 February 2021
What this trial tests

NA trial testing BCAA preparation Intravenous infusion in Liver Function Post BCAA Infusion in 60 participants. Completed in 10 September 2020.

Timeline
15 March 2018
Primary endpoint
27 August 2020
10 September 2020

Quick facts

Lead sponsorNational Hepatology & Tropical Medicine Research Institute
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment60
Start date15 March 2018
Primary completion27 August 2020
Estimated completion10 September 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

National Hepatology & Tropical Medicine Research Institute

Who can join

Adults 18 to 75, any sex, with Liver Function Post BCAA Infusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the impact of intravenous BCAAs infusion as adjunct therapy post liver surgery in intensive care unit (ICU).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Prospective randomized, placebo-controlled study: role of branched-chain amino acids infusion as adjunct therapy post-liver surgery for patients in the intensive care unit.
    Mahmoud EIE, Awdallah FF. · · 2025 · cited 2× · PMID 40537743 · DOI 10.1186/s12876-025-03696-3

Verify or expand the search:

Other National Hepatology & Tropical Medicine Research Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03448848.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing